Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Extracorporeal Membrane Oxygenation is Uniquely Complex: Response to A 'Fish Tank Model' to Teach Pharmacokinetics.

American journal of pharmaceutical education·2026
Same author

Suitability of sedative usage in patients undergoing cardiovascular surgery.

Expert review of cardiovascular therapy·2026
Same author

Venoarterial extracorporeal membrane oxygenation in adults with cardiogenic shock.

Frontiers in cardiovascular medicine·2026
Same author

Consensus Recommendations for Clinical Pharmacist Integration into the Acute Stroke Care Team: Endorsed by the American College of Clinical Pharmacy, Neurocritical Care Society, Society for Academic Emergency Medicine, and Society of Critical Care Medicine, and affirmed by the American Academy of Neurology.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Vasopressor use and atrial fibrillation after cardiac surgery.

The Annals of thoracic surgery·2026
Same author

Emergency Department Peer Recovery Support Services for Individuals with Substance Use Disorders: A Systematic Review of Comparative Studies.

Substance abuse and rehabilitation·2026

相关实验视频

Updated: Jun 2, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.4K

在体外膜氧化期间的抗凝血作用.

Troy Seelhammer1, Jacob Ninan2, Scott Nei3

  • 1Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.

The Cochrane database of systematic reviews
|January 13, 2025
PubMed
概括

本"柯克伦评审"协议检查了心脏或呼吸系统衰竭的患者体外膜氧化 (ECMO) 的抗凝剂. 它旨在评估这种干预措施在所有年龄段的有效性和安全性.

更多相关视频

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

255
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

319

相关实验视频

Last Updated: Jun 2, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.4K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

255
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

319

科学领域:

  • 关键护理医学 关键护理医学
  • 心血管医学 心血管医学
  • 呼吸系统药物 呼吸系统药物

背景情况:

  • 身体外膜氧化 (ECMO) 提供了重要的心肺呼吸支持.
  • 抗凝药对于预防ECMO期间的电路血栓形成至关重要.
  • 最佳的抗凝策略需要进一步研究.

研究的目的:

  • 评估抗凝固剂在维持ECMO方面的有效性.
  • 在ECMO期间评估抗凝固疗法的安全性.
  • 综合所有需要ECMO的年龄组的证据.

主要方法:

  • 这是柯克伦审查的协议.
  • 将采用系统审查方法.
  • 专注于评估ECMO抗凝剂的干预研究.

主要成果:

  • 结果正在等待系统审查的完成.
  • 将分析抗凝血剂的疗效数据.
  • 将报告安全数据,包括出血和血栓形成事件.

结论:

  • 在综合证据后,将得出结论.
  • 结果将为ECMO抗凝药的临床实践指南提供信息.
  • 将确定未来的研究方向.